# Sai Life Sciences Ltd (SAILIFE)
> Exchange: NSE | Sector: Healthcare | ISIN: 

## Price
Current Price: ₹1175.9
Day Change: +5.58%
52W High: ₹1139.4
52W Low: ₹707
Market Cap: ₹23,346 Cr

## Valuation
P/E: 69.6
P/B: 10.18
EPS: ₹15.82
Book Value: ₹108.17
Dividend Yield: 0%

## Returns
1Y Return: 27.85%

## Profitability
ROE: 15.13%
ROCE: 27.14%
Debt/Equity: 0.12
Revenue Growth: 6.6%
Profit Growth: 17.6%
EBITDA Margin: 30.35%
Operating Margin: 23.76%

## About
Sai Life Sciences Ltd is a Diagnostics & Research company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Healthcare
Industry: Diagnostics & Research
Sub Industry: Unknown

## Business Model
Overview: Sai Life Sciences Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Diagnostics & Research. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Healthcare.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Newspaper Publication
- Announcement: Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
- BSE Filing: Announcement under Regulation 30 (LODR)-Newspaper Publication

## Access
Current tier: anonymous
More history: Register free to see 4 more years.

## Data Freshness
Quote Updated: 2026-05-25T18:00:11.510Z
Price History Updated: 2026-05-25T05:29:19.999Z
Latest Price History Date: 2026-05-24
Technicals Updated: 2026-05-25T05:29:19.999Z
Quant Updated: 2026-05-25T05:29:19.999Z
Sentiment Updated: 2026-05-25T05:29:19.999Z
Financials Status: current
Financials Updated: 2026-05-18T08:31:51.323Z
Financials Last Attempt: 2026-05-18T08:31:51.323Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2020)
Revenue: ₹695 Cr
Operating Profit: ₹176 Cr (OPM 25%)
Net Profit: ₹73 Cr
Tax: ₹113 Cr

## Annual P&L History
Mar 2020: Rev ₹695Cr | PAT ₹73Cr | OPM 25%
Mar 2021: Rev ₹726Cr | PAT ₹76Cr | OPM 23%
Mar 2022: Rev ₹760Cr | PAT ₹61Cr | OPM 22%

## Balance Sheet (Mar 2020)
Total Assets: ₹1215 Cr
Total Liabilities: ₹1215 Cr
Borrowings: ₹249 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Ranga Raju Kanumuri, Executive Chairman
- Krishnam Raju Kanumuri, CEO, MD & Executive Director
- Sivaramakrishnan  Chittor, CFO & Whole Time Director
- Runa  Karan, Company Secretary, Compliance Officer & Legal Head
- Sriram  Gopalakrishnan, Vice President of Corporate Communication

---
Source: rupiya.io/stocks/sailife
Disclaimer: For research and education only. Not investment advice.